Enhanced expression of TIGIT in the TME has been revealed in patients with GC, along with increased expression of its ligands, CD155 and CD112, which is correlated with immune evasion caused by CD8+ T cell repression [169]. The gene discussed is TIGIT; the disease is gastric cancer.